Transmyocardial laser revascularization versus medical therapy for refractory angina

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Briones, Eduardo ^a   Lacalle, Juan Ramon ^b   Marin, Ignacio ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Angina pectoris mortality; *therapy ; Humans; Laser therapy *methods ; Myocardial revascularization *methods ; Randomized controlled trials as topic

Indexed keywords

ANTIANGINA PECTORIS AGENT; ANTICOAGULANT AGENT; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM;

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; DISEASE COURSE; DISEASE SEVERITY; EXERCISE TOLERANCE; HEART EJECTION FRACTION; HEART FUNCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL; SYMPTOM; SYSTEMATIC REVIEW; THORACOTOMY; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; TREADMILL EXERCISE; TREATMENT DURATION; TREATMENT OUTCOME; YAG LASER;

EID: 70249107446     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003712.pub2     Document Type: Review

References (74)

1. Aaberge L, Askhus S, Nordstrand K, Abdelnoor M, Ihlen H, Forfang K. Myocardial performance after transmyocardial revascularization with CO(2)laser. A dobutamine stress echocardiographic study. European Journal of Echocardiography 2001;2:187-196 (Pubitemid 32842624)
2. Aaberge L, Nordstrand K, Dragsund M, Saatvedt K, Endresen K, Golf S, et al. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian Randomized Trial. Journal of the American College of Cardiology 2000;35:1170-1177
3. *Aaberge L, Rootwelt K, Blomhoff S, Saatvedt K, Abdelnoor M, Forfang K. Continued symptomatic improvement three to five years after transmyocardial laser revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial laser revascularization. Journal of the American College of Cardiology 2002;39:1588-1593
4. Aaberge L, Rootwelt K, Smith HJ, Nordstrand K, Forfang K. Effects of transmyocardial revascularization on myocardial perfusion and systolic function assessed by nuclear andmagnetic resonance imaging methods. Scandinavian Cardiovascular Journal 2001;35:8-13. (Pubitemid 32318460)
5. Allen KB, Dowling RD, Angell WW, Gangahar DM, Fudge TL, Richenbacher W, et al. Transmyocardial laser revascularization: 5 years follow-up of a prospective, randomized trial. Annals of Thoracic Surgery 2004;77:1228-1234 (Pubitemid 38452353)
6. * Allen KB, Dowling RD, Fudge TL, Schoettle P, Sleinger SL, Gangahar DM, et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. The New England Journal of Medicine 1999;341:1029-1036
7. * Burkhoff D, Schmidt S, Schulman SP, Myers J, Resar J, Becker LC, et al. Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomized trial. Lancet 1999;354:885-890
8. * Frazier OH, March RJ, Horvath KA, for the transmyocardial carbon dioxide laser revascularization group. Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. New England Journal of Medicine 1999;341: 1021-1028
9. Hovarth KA, Aranki SF, Cohn LH, March RJ, Frazier OH, Kadipasaoglu KA, et al. Sustained angina relief 5 years after transmyocardial laser revascularization with a CO(2) laser. Circulation 2001;104 (12 Suppl 1):I81-I84. (Pubitemid 32884782)
10. March RJ. Transmyocardial laser revascularization with the CO2 laser: one year results of a randomized, controlled trial. Seminars in Thoracic and Cardiovascular Surgery 1999;11(1):12-18
11. Spertus JA, Jones PG, Coen M, Garg M, Bliven B, O'Keefe J, et al. Transmyocardial CO2 laser revascularization improves symptons, function and quality of life: 12-month results from a randomized controlled trial. American Journal of Medicine 2001;111:341-348 (Pubitemid 32913665)
12. Jones JW, Schmidt SE, Richman BW, Miller CC, Sapire KJ, Burkhoff D, et al. Holmium: YAG laser transmyocardial revasculariazation relieves angina and improves functional status. Annals of Thoracic Surgery 1999;67:1596-1602. (Pubitemid 29301297)
13. Burns SM, Brown S, White CA, Tait S, Sharples L, Schofield PM. Quantitative analysis of myocardial perfusion changes with transmyocardial laser revascularization. American Journal of Cardiology 2001; 87(7):861-867 [CENTRAL: CN-00372857] (Pubitemid 32244205)
14. Caine N, Tait S, Campbell H, Buxton M, Sharples LD, Schofield PM, et al. The UK trial of transmyocardial laser revascularisation (TMLR): cost effectiveness. 15th Annual Meeting of the International Society of Technology Assessment in Health Care; 1999 Jun 20-23. 1999: 122.
15. Campbell HE, Tait S, Buxton MJ, Sharples LD, Caine N, Schofield PM, et al. A UK trial-based cost-utility analysis of transmyocardial laser revascularization compared to continued medical therapy for treatment of refractory angina pectoris. European Journal of Cardio-Thoracic Surgery 2001;20:312-318 (Pubitemid 32706613)
16. Campbell HE, Tait S, Sharples LD, Caine N, Gray TJ, Schofield PM, et al. Trial-based cost-utility comparison of percutaneous myocardial laser revascularisation and continued medical therapy for treatment of refractory angina pectoris. European Journal of Health Economics 2005;6(4):288-297 [CENTRAL: CN-00552367] (Pubitemid 41779927)
17. * Schofield PM, Sharples LD, Caine N, Burns S, Tait S, Wistow, T, et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet 1999;353:519-524
18. Tait S, Caine N, Batas D, Sharples LD, Buxton M, Burns S, et al. The UK trial of transmyocardial laser revascularisation (TMLR): health related quality of life (HRQOL) [abstract]. 15th Annual Meeting of the International Society of Technology Assessment in Health Care; 1999 Jun 20-23 1999:62. [CENTRAL: CN-00476490]
19. * Huikeshoven M, van der Sloot JAP, Tukkie R, van Gemert MJC, Tijssen JGP, Beek JF. Improved quality of life after XeCl excimer transmyocardial laser revascularization: results of a randomized trial. Lasers in Surgery and Medicine 2003;33:1-7. [DOI: 10.1002/lsm.10189]
20. van der Sloot JAP, Huikeshoven M, Tukkie R, Verbene HJ, van der Meulen J, van Eck-Smit BLF, et al. Transmyocardial revascularization using an XeCl excimer laser: Results of a randomized trial. Annals of Thoracic Surgery 2004;78(3):875-881 (Pubitemid 39164796)
21. Allen KB, Dowling RD, DelRossi AJ, Realyvasques F, Lefrak EA, Pfeffer TA, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. Journal of Thoracic and Cardiovascular Surgery. 2000;119(3):540-549 [CENTRAL: CN-00275669] (Pubitemid 30146534)
22. Appelman YE, Piek JJ, Strikwerda S, Tijssen JG, de Feyter PJ, David GK, et al. Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease. Lancet. 1996;347(8994):79-84. [CENTRAL: CN-00122402] (Pubitemid 26017852)
23. Appelman YE, Piek JJ, Redekop WK, de Feyter PJ, Koolen JJ, David GK, et al. Clinical events following excimer laser angioplasty or balloon angioplasty for complex coronary lesions: subanalysis of a randomised trial. Heart (British Cardiac Society) 1998;79(1):34-38 [CENTRAL: CN-00148577]
24. Appelman YE, Piek JJ, van der Wall EE, Redekop WK, van Royen EA, Fioretti PM, et al. Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions. International Journal of Cardiac Imaging. 2000;16 (4):267-277 [CENTRAL: CN-00327681]
25. Dixon SR, Schreiber TL, Rabah M, Lee DT, Kelco KL, O'Neill WW. Immediate effect of percutaneous myocardial laser revascularization on hemodynamics and left ventricular systolic function in severe angina pectoris. American Journal of Cardiology 2001;87(5): 516-519 [CENTRAL: CN-00328342] (Pubitemid 32178442)
26. Dowling R, Thielmeier K, Ghaly A, Barber D, Boice T, Dine A. Improved pain control after cardiac surgery: results of a randomized, double-blind, clinical trial. Journal of Thoracic and Cardiovascular Surgery. 2003;126(5):1271-1278 [CENTRAL: CN-00459447] (Pubitemid 37449151)
27. Dziuk M, el-Deeb H, Britton KE, Edmondson SJ, Piechota W, Cholewa M. Clinical outcome of patients after transmyocardial laser revascularization alone and combined with coronary artery bypass grafting [Kliniczna ocena efektu przezsercowej rewaskularyzacji laserowej polaczonej lub niepolaczonej z pomostowaniem aortalno-wiencowym.]. Polski Merkuriusz Lekarski 2003;15(90): 534-536 [CENTRAL: CN-00559730]
28. Frazier OH, Tuzun E, Eichstadt H, Boyce SW, Lansing AM, March RJ, et al. Transmyocardial laser revascularization as an adjunct to coronary artery bypass grafting: a randomized, multicenter study with 4-year follow-up. Texas Heart Institute Journal 2004;31(3):231-239 [CENTRAL: CN-00492808] (Pubitemid 39202704)
29. Guleserian KJ, Maniar HS, Camillo CJ, Bailey MS, Damiano RJ, Moon MR. Quality of life and survival after transmyocardial laser revascularization with the holmium:YAG laser. Annals of Thoracic Surgery 2003;75(6):1842-7; discussion 1847-1848 [CENTRAL: CN-00558872]
30. Horvath KA. Results of clinical trials of transmyocardial laser revascularization versus medical management for end-stage coronary disease. Journal of Clinical Laser Medicine & Surgery 2000;18(5):247-252
31. Horvath KA. Transmyocardial laser revascularization in the treatment of myocardial ischemia. Journal of Cardiac Surgery 2000;15(4):271-277 (Pubitemid 32955138)
32. Horvath KA. Results of prospective randomized controlled trials of transmyocardial laser revascularization. Heart Surgery Forum 2002;5 (1):33-39 (Pubitemid 34308435)
33. Kniazeva TA, Nagapet'ian VK. The use of infrared laser radiation in the rehabilitation of IHD patients after the surgical revascularization of the myocardium [Ispol'zovanie infrakrasnogo lazernogo izlucheniia v reabilitatsii bol'nykh IBS posle khirurgicheskoi revaskuliarizatsii miokarda]. Voprosy Kurortologii, Fizioterapii, i Lechebnoi Fizicheskoi Kultury 1994, (6):10-12 [CENTRAL: CN-00114479]
34. Leon MB, Kornowski R, Downey WE, Weisz G, Baim DS, Bonow RO, et al. A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease. Journal of the American College of Cardiology. 2005;46(10):1812-1819 [CENTRAL: CN-00531924] (Pubitemid 41579801)
35. Loubani M, Chin D, Leverment JN, Galiñanes M. Mid-term results of combined transmyocardial laser revascularization and coronary artery bypass. Annals of Thoracic Surgery 2003;76(4):1163-1166 [CENTRAL: CN-00458111] (Pubitemid 37204726)
36. McNab D, Khan SN, Sharples LD, Ryan JY, Freeman C, Caine N, et al. An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial. European Heart Journal 2006;27(9):1048-1053 [CENTRAL: CN-00563544] (Pubitemid 43954933)
37. Milano, Carlo AD. Transmyocardial revascularization with a holmium laser: preliminary results [Rivascolarizzazione transmiocardica con laser ad olmio: risultati preliminari]. Giornale Italiano Di Cardiologia 1997;27(10):1011-1018 [CENTRAL: CN-00338266]
38. Myers J, Oesterle SN, Jones J, Burkhoff D. Do transmyocardial and percutaneous laser revascularization induce silent ischemia? An assessment by exercise testing. American Heart Journal 2002;143(6): 1052-1057 (Pubitemid 34666898)
39. Oesterle SN. Laser percutaneousmyocardial revascularization. American Journal of Cardiology 1999;83(4 A):46B-52B. [CENTRAL: CN-00413614]
40. Oesterle SN, Sanborn TA, Ali N, Resar J, Ramee SR, Heuser R, et al. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential Class Improvement From Intramyocardial Channels. Lancet 2000;356(9243): 1705-1710 [CENTRAL: CN-00331210]
41. Salem M, Rotevatn S, Stavnes S, Brekke M, Vollset SE, Nordrehaug JE. Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris. American Journal of Cardiology 2004;93(9):1086-1091 [CENTRAL: CN-00469504] (Pubitemid 38521034)
42. Salem M, Rotevatn S, Stavnes S, Brekke M, Pettersen R, Kuiper K, et al. Release of cardiac biochemical markers after percutaneous myocardial laser or shamprocedures. International Journal of Cardiology 2005;104(2):144-151 [CENTRAL: CN-00552248] (Pubitemid 41316982)
43. Salem M, Rotevatn S, Nordrehaug JE. Long-term results following percutaneous myocardial laser therapy. Coronary artery disease 2006; 17(4):385-390 [CENTRAL: CN-00565446] (Pubitemid 44309799)
44. Stone GW, Teirstein PS, Rubenstein R, Schmidt D, Whitlow PL, Kosinski EJ, et al. A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions. Journal of the American College of Cardiology 2002;39(10):1581-1587 [CENTRAL: CN-00380195] (Pubitemid 34495472)
45. Vasil'ev AP, Strel'tsova NN, Senatorov IuN. Efficacy of laser therapy in patients with ischemic heart disease [Effektivnost' lazeroterapii bol'nykh ishemicheskoi bolezn'iu serdtsa]. Voprosy Kurortologii, Fizioterapii i Lechebnoi Fizicheskoi Kultury 2003, (4):10-13 [CENTRAL: CN-00457587]
46. Aaberge L, Rootwelt K, Blomhoff S, Saatvedt K, Abdelnoor M, Forfang K. Continued symptomatic improvement three to five years after transmyocardial laser revascularization with CO(2) laser: a late clinical follow-up of the Norwegian Randomized trial with transmyocardial laser revascularization. Journal of the American College of Cardiology 2002;39:1588-1593 (Pubitemid 34494280)
47. Allen KB, Dowling RD, Schuch DR, Pfeffer TA, Marra S, Lefrak EA, et al. Adjunctive transmyocardial revascularization: five-year followup of a prospective, randomized trial. Annals of Thoracic Surgery 2004;78(2):458-465 [: CN-00510874] (Pubitemid 38980752)
48. Bienenfeld L, Frishman W, Glasser SP. The placebo effect in cardiovascular disease. American Heart Journal 1996;132(6):1207-1221
49. Briones E, Rodriguez FJ. Eficacia, seguridad y eficiencia de la revascularización transmiocárdica con láser [Efficacy, security and efficiency of transmyocardial laser revascularization]. Madrid: Ministerio de Sanidad y Consumo, 2003. [: ISBN 84-760-664-2]
50. Burkhoff D, Jones JW, Becker LC. Variability of myocardial perfusion defects by thallium 201 scintigraphy in patients with coronary artery disease not amenable to angioplasty or bypass surgery. Journal of the American College of Cardiology 2001;38:1033-1039 (Pubitemid 32912708)
51. Caine N, Schofield PM, Wallwork J, Sharples LD. British trial of transmyocardial revascularisation is continuing. BMJ 1998;316 (7129):474-475 [CENTRAL: CN-00258677] (Pubitemid 28121317)
52. Cooley DA, Frazier OH, Kadipasaoglu KA, Lindenmeir MH, Pehlivanoglu S, Kolff JW, et al. Transmyocardial laser revascularization: clinical experience with twelve-month follow-up. Journal of Thoracic and Cardiovascular Surgery 1996;111:791-797 (Pubitemid 26118859)
53. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-1291 (Pubitemid 24340510)
54. Downing SW. Transmyocardial laser revascularization. New England Journal of Medicine 2000;342:436-438
55. Frazier OH, Cooley DA, Kadipasaoglu KA, Pehlivanoglu S, Lindenmeir MH, Barasch E, et al. Myocardial revascularization with laser: preliminary findings. Circulation 1995;92(Suppl II):58-65.
56. Horvath KA, Mannting F, Cummings N, Shernan SK, Cohn LH. Transmyocardial laser revascularization: operative techniques and clinical results at two years. Journal of Thoracic and Cardiovascular Surgery 1996;111:1047-1053 (Pubitemid 26146059)
57. Kim MC, Kini A, Sharma SK. Refractory angina pectoris. Journal of the American College of Cardiology 2002;39:923-934
58. Lange RA, Hillis LD. Transmyocardial laser revascularization. New England Journal of Medicine 1999;341:1075-1076
59. Lefebvre C, McDonald S. Development of a sensitive search strategy for reports of randomised controlled trials in EMBASE. Paper presented at the Fourth International Cochrane Colloquium 20-24 Oct. Adelaide, Australia. 1996.
60. Liao L, Sarria-Santamera A, Matchar DB, Huntington AH, Lin S, et al. Meta-analysis of survival and relief of angina pectoris after transmyocardial revascularization. American Journal of Cardiology 2005; 95:1243-1245 [DOI: 10.1016/j.amjcard.2005.01.057] (Pubitemid 40616432)
61. Macklin R. The ethical problems with sham surgery in clinical research. New England Journal of Medicine 1999;341(13):992-996 [MEDLINE: 10498498] (Pubitemid 29441557)
62. Mirhoseini M, Muckerheide M, Cayton MM. Transventricular revascularization by laser. Lasers in Surgery andMedicine 1982;2:187-198
63. Mirhoseini M, Shelgikar S, Cayton MM. Transmyocardial laser revascularization: a review. Journal of Clinical Laser Medicine & Surgery 1993;11:15-19
64. Medicare Service Advisory Committee. Transmyocardial laser revascularization. Canberra: Commonwealth of Australia, 1999.
65. Mukherjee D, Bhatt DL, Roe MT, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis - how many patients might be eligible?. American Journal of Cardiology 1999;84(5):598-600. (Pubitemid 29408596)
66. Nägele H, Stubbe HM, Nienaber C, Rodiger W. Results of transmyocardial laser revascularization in non-revascularizable coronary artery disease after 3 years follow-up. European Heart Journal 1998; 19(10):1525-1530 (Pubitemid 28470474)
67. Peduzzi P, Detre K, Wittes J, Holford T. Intent-to-treat analysis and the problem of crossovers. An example from the Veterans Administration coronary bypass surgery study. Journal of Thoracic and Cardiovascular Surgery 1991;101:481-487
68. Peterson ED, Kaul P, Kaczmarek RG, Hammill BG, Armstrong PW, Bridges CR, et al. From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes. Journal of the American College of Cardiology 2003;42(9):1611-1616 (Pubitemid 37378442)
69. Prêtre R, Turina MI. Laser to the heart: magic but costly, or only costly?. Lancet 1999;353:512-513
70. Saririan M, Eisenberg MJ. Myocardial laser revascularization for the treatmen of end-stage coronary artery disease. Journal of the American College of Cardiology 2003;41(2):173-183 (Pubitemid 36092180)
71. Sharples L, Schofield P, Caine N, Wallwork J. Transmyocardial laser revascularisation in clinical practice. Lancet 1999;354:1994-1995
72. Smith JA, Dunning JJ, Parry AJ, Large SR, Wallwork J. Transmyocardial laser revascularization. Journal of Cardiac Surgery 1995;10 (5):569-572 [CENTRAL: CN-00120891]
73. Williams Sg, Wright DJ, Lindsay SJ, Tan LB. Transmyocardial laser revascularisation in clinical practice. Lancet 1999;354:1994-1995
74. Williams SG, Wright DJ, Tan LB. Transmyocardial laser revascularization. New England Journal of Medicine 2000;342:436-438